Authors: MCDOWALL JE MACKIE AE VENTRESCA GP BYE A

Citation: Je. Mcdowall et al., PHARMACOKINETICS AND BIOAVAILABILITY OF INTRANASAL FLUTICASONE IN HUMANS, Clinical drug investigation, 14(1), 1997, pp. 44-52

Authors: FALCOZ C MACKIE AE MOSS J HORTON J VENTRESCA GP BROWN A FIELD E HARDING SM WIRE P BYE A

Citation: C. Falcoz et al., PHARMACOKINETICS OF FLUTICASONE PROPIONATE INHALED FROM THE DISKHALER(R) AND THE DISKUS(R) AFTER REPEAT DOSES IN HEALTHY-SUBJECTS AND ASTHMATIC-PATIENTS, Journal of allergy and clinical immunology, 99(1), 1997, pp. 2041-2041

Authors: VENTRESCA GP

Citation: Gp. Ventresca, CLINICAL-PHARMACOLOGY OF HFA134A, Journal of aerosol medicine, 8, 1995, pp. 35-39

Authors: MCDOWALL JE MACKIE AE BYE A VENTRESCA GP

Citation: Je. Mcdowall et al., LOW SYSTEMIC EXPOSURE TO INTRANASAL FLUTICASONE PROPIONATE, Journal of allergy and clinical immunology, 95(1), 1995, pp. 194-194

Authors: PIKE VW AIGBIRHIO FI FREEMANTLE CAJ PAGE BC RHODES CG WATERS SL JONES T OLSSON P VENTRESCA GP TANNER RJN HAYES M HUGHES JMB

Citation: Vw. Pike et al., DISPOSITION OF INHALED 1,1,1,2-TETRAFLUOROETHANE (HFA134A) IN HEALTHY-SUBJECTS AND IN PATIENTS WITH CHRONIC AIR-FLOW LIMITATION - MEASUREMENT BY F-18 LABELING AND WHOLE-BODY GAMMA-COUNTING, Drug metabolism and disposition, 23(8), 1995, pp. 832-839

Authors: KIRBY SM SMITH J VENTRESCA GP

Citation: Sm. Kirby et al., SALMETEROL INHALER USING A NON-CHLORINATED PROPELLANT, HFA134A - SYSTEMIC PHARMACODYNAMIC ACTIVITY IN HEALTHY-VOLUNTEERS, Thorax, 50(6), 1995, pp. 679-681